Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Total Liabilities (2020 - 2025)

iSpecimen has reported Total Liabilities over the past 6 years, most recently at $6.4 million for Q4 2025.

  • For Q4 2025, Total Liabilities rose 6.69% year-over-year to $6.4 million; the TTM value through Dec 2025 reached $6.4 million, up 6.69%, while the annual FY2025 figure was $6.4 million, 6.69% up from the prior year.
  • Total Liabilities for Q4 2025 was $6.4 million at iSpecimen, up from $5.9 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $31.2 million in Q1 2021 and troughed at $2.9 million in Q2 2023.
  • A 5-year average of $6.8 million and a median of $5.7 million in 2022 define the central range for Total Liabilities.
  • Biggest five-year swings in Total Liabilities: crashed 82.0% in 2022 and later skyrocketed 103.25% in 2024.
  • Year by year, Total Liabilities stood at $5.9 million in 2021, then dropped by 27.32% to $4.3 million in 2022, then surged by 41.07% to $6.1 million in 2023, then fell by 0.64% to $6.0 million in 2024, then grew by 6.69% to $6.4 million in 2025.
  • Business Quant data shows Total Liabilities for ISPC at $6.4 million in Q4 2025, $5.9 million in Q3 2025, and $5.4 million in Q2 2025.